SSII
SS Innovations International Inc. Common StockSSII
SSII
About: SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India.
Employees: 378
–
Funds holding %
of 7,323 funds
–
Analysts bullish %
Fund manager confidence
Research analyst outlook
We haven’t received any recent analyst ratings for SSII.
Financial journalist opinion
Based on 6 articles about SSII published over the past 30 days
Neutral
MCAP MediaWire
1 week ago
SS Innovations Announces Completion of World's First Intercontinental Robotic Cardiac Telesurgery
Performed by Dr. Sudhir Srivastava utilizing the Company's SSi Mantra 3 surgical robotic system Remotely conducted from IRCAD in Strasbourg, France at an unprecedented distance of more than 4,000 miles to the operating room at SAIMS in Indore, India Fort Lauderdale, FL, July 22, 2025 – PRISM MediaWire – SS Innovations International, Inc.
Neutral
GlobeNewsWire
1 week ago
SS Innovations Announces Completion of World's First Intercontinental Robotic Cardiac Telesurgery
Performed by Dr. Sudhir Srivastava utilizing the Company's SSi Mantra 3 surgical robotic system Remotely conducted from IRCAD in Strasbourg, France, at an unprecedented distance of more than 4,000 miles to the operating room at SAIMS in Indore, India FORT LAUDERDALE, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company's Chairman of the Board and Chief Executive Officer, Dr. Sudhir Srivastava, M.D.
Neutral
MCAP MediaWire
2 weeks ago
SS Innovations Surpasses Milestone of 100 Installations of the SSi Mantra Surgical Robotic System
Continuing strong procedure growth, including an upsurge in telesurgeries Fort Lauderdale, FL, July 15, 2025 – PRISM MediaWire – SS Innovations International, Inc.
Neutral
GlobeNewsWire
2 weeks ago
SS Innovations Surpasses Milestone of 100 Installations of the SSi Mantra Surgical Robotic System
FORT LAUDERDALE, Fla., July 15, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company has installed more than 100 SSi Mantra surgical robotic systems in India and six other countries.
Neutral
MCAP MediaWire
2 weeks ago
SS Innovations Announces Completion of World's First Robotic Telesurgery for Weight Loss with the Company's SSi Mantra 3 Surgical Robotic System
Fort Lauderdale, FL, July 10, 2025 – PRISM MediaWire – SS Innovations International, Inc.
Neutral
GlobeNewsWire
2 weeks ago
SS Innovations Announces Completion of World's First Robotic Telesurgery for Weight Loss with the Company's SSi Mantra 3 Surgical Robotic System
Led by Dr. Mohit Bhandari, a pioneer in bariatric surgery and President of the Institute of Research Against Digestive Cancer (IRCAD) India, the surgery was remotely performed at a distance of 560 miles and executed on-site at Mohak Bariatric & Robotic Surgery Centre in Indore, India. Two advanced One-Anastomosis Gastric Bypass (OAGB) procedures were performed via telesurgery, with zero perceptible lag, flawless precision, and seamless robotic control using the SSI Mantra 3 system.
Positive
Seeking Alpha
1 month ago
SS Innovations: A Speculative Bet On Robotic Surgeries
SSII is rapidly growing its surgical robotics business, with strong revenue and KPI growth while expanding into new international markets. Despite operating losses and dilution risk, I see a path to profitability as installations and instrument sales accelerate. The stock is aggressively valued, but industry-leading growth and sector hype justify a speculative buy for risk-tolerant investors.
Neutral
MCAP MediaWire
1 month ago
SS Innovations Announces Successful Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company's SSi Mantra 3 Surgical Robotic System
Surgery performed by Dr. Juan Zuniga at Interhospital in Guayaquil, Ecuador PR Audio: Fort Lauderdale, FL, June 16, 2025 – PRISM MediaWire – SS Innovations International, Inc.
Neutral
GlobeNewsWire
1 month ago
SS Innovations Announces Successful Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company's SSi Mantra 3 Surgical Robotic System
SS Innovations Announces Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company's SSi Mantra 3 Surgical Robotic System
Neutral
MCAP MediaWire
1 month ago
SS Innovations to Ring the Nasdaq Opening Bell on Tuesday, June 3, 2025
Fort Lauderdale, FL, June 2, 2025 – PRISM MediaWire – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company will ring the opening bell at the Nasdaq MarketSite in New York City on Tuesday, June 3, 2025. Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, will lead the bell ringing ceremony and be joined by members of the Company's management team, Board of Directors, advisors, and other guests.
Charts implemented using Lightweight Charts™